ArticleJournal of thoracic disease2026
CT-based radiomics and intratumoral heterogeneity for predicting benign and malignant lesions in solid pulmonary nodules.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of a radiomics-habitat model for preoperatively predicting poorly differentiated stage IA lung adenocarcinoma.Journal of thoracic disease · 2026Article
- Recent advances in artificial intelligence across interventional pulmonology: a narrative review.Journal of thoracic disease · 2026Review
- Radiomics-derived classifier performance evaluation in lung nodule characterization compared with expert radiologists.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains one of the leading causes of cancer-related deaths worldwide. This study utilized clinical risk factors along with intratumoral radiomics, peritumoral radiomics, and intratumoral subregional features extracted from computed tomography (CT) lung-window images for individual and integrated modeling to classify solid pulmonary nodules and identify the optimal model, thereby improving diagnostic accuracy while minimizing unnecessary invasive procedures. Methods: CT images of 230 pathologically confirmed solitary solid pulmonary nodules were retrospectively collected from two hospitals. Among the 167 patients from the first hospital, 20% (n=34) served as the test set, while the remaining 80% (n=133) were used as the training and development set for 5-fold cross-validation, while data from the second hospital (n=63) served as an external test set. Intratumoral and peritumoral regions of interest (ROIs) were delineated on lung window images, and relevant radiomics features were extracted. Multiple machine learning algorithms-including Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Linear Support Vector Classifier (Linear SVC) etc.-were employed to construct predictive models for distinguishing benign from malignant solid pulmonary nodules. Results: A triple-feature model (intratumoral, peritumoral, clinical) achieved superior diagnostic performance [area under the receiver operating characteristic curve (AUC): training 0.932, 95% confidence interval (CI): 0.897-0.960; test 0.833, 95% CI: 0.773-0.890; external test 0.741, 95% CI: 0.618-0.864] with high sensitivity/specificity. The intratumoral-peritumoral dual-modality model showed optimal cross-center robustness external test, AUC =0.808 (95% CI: 0.700-0.922). Habitat imaging revealed heterogeneity, AUC =0.750 (95% CI: 0.676-0.825). Decision curve analysis confirmed the triple-model's clinical utility. SHAP identified age, gender, and key radiomics (e.g., gradient_firstorder_Skewness_Intra) as top predictors. Multi-center test confirmed generalizability, positioning this integrated framework as a robust tool to reduce invasive procedures in pulmonary nodule management. Conclusions: The multi-combination models developed in this study enhance the diagnostic accuracy for distinguishing benign from malignant solid pulmonary nodules, with the triple-feature model demonstrating the highest diagnostic performance. This approach has the potential to spare patients from unnecessary invasive procedures and strengthen clinical decision-making in the management of pulmonary nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.